OncoSec Medical Incorporated (Nasdaq: ONCS) announced that new clinical data from the Phase II Investigator Sponsored Trial led by the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE